SEER

Seer Inc

1.66

Jun 30 • 04:00PM ET 0.00 (0.00%)

Healthcare Biotechnology USA Micro NASD

Peers: AARD AGEN CNTB GALT IMUX KZIA NTHI ONCY SPRO VRCA

| Held by: VTI VXF IWC AVSC DFMC PRFZ DFSU AVUS DXUV DFAS

Scroll to Statements

Index	-
Market Cap	91.82M
Enterprise Value	-51.82M
Income	-70.49M
Sales	15.04M
Book/sh	4.39
Cash/sh	3.01
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	124
IPO	Dec 04, 2020

P/E	-
Forward P/E	-
PEG	-
P/S	6.11
P/B	0.38
P/C	0.55
P/FCF	-
EV/EBITDA	-
EV/Sales	-3.45
Quick Ratio	16.94
Current Ratio	17.73
Debt/Eq	0.10
LT Debt/Eq	0.08
Option/Short	Yes / Yes

EPS (ttm)	-1.24
EPS next Y	-0.73
EPS next Q	-0.21
EPS this Y	35.55%
EPS next Y	11.52%
EPS next 5Y	20.22%
EPS past 3/5Y	4.89% -18.95%
Sales past 3/5Y	3.15% 89.71%
EPS Y/Y TTM	11.50%
Sales Y/Y TTM	-1.44%
EPS Q/Q	10.45%
Sales Q/Q	-33.58%
Earnings	May 13 AMC
EPS/Sales Surpr.	-1.69% -22.42%

Insider Own	34.58%
Insider Trans	-0.21%
Inst Own	23.46%
Inst Trans	-7.84%
ROA	-22.76%
ROE	-25.52%
ROIC	-26.92%
Gross Margin	48.26%
Oper. Margin	-496.38%
Profit Margin	-468.74%
SMA20	-4.41%
SMA50	-8.53%
SMA200	-13.56%
Trades

Shs Outstand	55.07M
Shs Float	36.19M
Short Float	0.53%
Short Ratio	0.59
Short Interest	0.19M
52W High	2.41 -31.12%
52W Low	1.65 0.61%
Volatility	3.37% 2.88%
ATR (14)	0.06
RSI (14)	37.60
Beta	1.59
Rel Volume	0.52
Avg Volume	324.10K
Volume	168,801

Perf Week	-4.05%
Perf Month	-11.23%
Perf Quarter	-1.19%
Perf Half Y	-9.78%
Perf YTD	-9.29%
Perf Year	-22.43%
Perf 3Y	-61.12%
Perf 5Y	-94.94%
Perf 10Y	-
Recom	1.00
Target Price	4.00
Prev Close	1.66
Price	1.66
Change	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
May-04-26	Initiated	Canaccord Genuity	Buy	$4
Jul-05-23	Resumed	JP Morgan	Neutral	$10
Jan-04-23	Downgrade	BofA Securities	Neutral → Underperform	$9 → $6.50
Aug-11-22	Downgrade	JP Morgan	Overweight → Neutral	$20 → $12
Oct-15-21	Resumed	Cowen	Outperform
Dec-29-20	Initiated	Morgan Stanley	Equal-Weight	$65
Dec-29-20	Initiated	JP Morgan	Overweight	$75
Dec-29-20	Initiated	Cowen	Outperform
Dec-29-20	Initiated	BofA Securities	Neutral	$69

Jun-29-26 04:10PM	The Radoff-JEC Group Releases Presentation Highlighting Why Seer, Inc. Stockholders Should Vote for Boardroom Change (Business Wire)
Jun-24-26 08:45AM	The Radoff-JEC Group Urges Seer, Inc. Stockholders to Vote for Boardroom Change Today (Business Wire)
Jun-22-26 07:00AM	Seer and Korea University Present Preliminary Data at ASMS 2026 Demonstrating Potential of AI-Driven Plasma Proteomics for Multi-Cancer Screening (GlobeNewswire)
Jun-15-26 08:00AM	The Radoff-JEC Group Highlights Seer Inc.'s and Chairman and CEO Omid Farokhzad, M.D.'s History of Value Destruction (Business Wire)
07:00AM	Seer Board of Directors Issues Letter to Shareholders Highlighting the Company's Significant Scientific Progress and Addressing Radoff and Torok's Short-Sighted Campaign (GlobeNewswire)
06:00PM	Loading…
Jun-03-26 06:00PM	Seer Files Definitive Proxy Materials and Mails Letter to Stockholders (GlobeNewswire)
May-29-26 07:00AM	Seer Files ITC Complaint Against Nanomics (GlobeNewswire)
May-27-26 04:30PM	The Radoff-JEC Group Calls on Seer Inc. and Its Advisors to Reevaluate Its Premium Acquisition Proposal in the Best Interests of All Stockholders (Business Wire)
May-26-26 04:05PM	Seer to Showcase AI-Driven Multi-Cancer Screening Approach and Next-Generation Proteomics Capabilities at ASMS 2026 (GlobeNewswire)
May-21-26 04:38PM	Seer Board of Directors Unanimously Rejects Further Revised Unsolicited Proposal from Radoff-JEC Group (GlobeNewswire) +5.36%
May-14-26 08:30AM	Seer, Inc. Q1 2026 Earnings Call Summary (Moby)
08:00AM	The Radoff-JEC Group Submits its Third Non-Binding Proposal to Acquire Seer, Inc. (Business Wire)
01:01AM	Seer Inc (SEER) Q1 2026 Earnings Call Highlights: Navigating Revenue Decline Amid Competitive ... (GuruFocus.com)
May-13-26 04:05PM	Seer Reports First Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook (GlobeNewswire)
07:00AM	Seer Files Patent Infringement Lawsuit Against Nanomics (GlobeNewswire)
09:22AM	Loading…
May-12-26 09:22AM	Earnings To Watch: Seer Inc (SEER) Reports Q1 2026 Result (GuruFocus.com)
May-04-26 07:00AM	Seer Announces Appointment of Anthony Bazarko as Chief Commercial Officer (GlobeNewswire)
Apr-29-26 04:05PM	Seer to Report First Quarter 2026 Financial Results on May 13, 2026 (GlobeNewswire)
08:00AM	The Radoff-JEC Group Responds to Seer, Inc.s Rejection of April 24th Acquisition Proposal (Business Wire)
Apr-27-26 07:00AM	Seer Board of Directors Unanimously Rejects Revised Unsolicited Proposal from Radoff-JEC Group (GlobeNewswire)
Apr-24-26 07:00AM	The Radoff-JEC Group Submits Improved Non-Binding Proposal to Acquire Seer, Inc. (Business Wire)
Apr-13-26 01:55PM	Seer Confirms Receipt of Unsolicited Proposal and Director Candidate Nominations from Radoff-JEC Group (GlobeNewswire) +13.61%
08:00AM	The Radoff-JEC Group Submits Non-Binding Proposal to Acquire Seer, Inc. (Business Wire)
Apr-09-26 08:00AM	Seer and Precision Health Research, Singapore Sign Collaboration to Provide Deep, Unbiased Proteomics on 10,000 PRECISE SG100K Samples (GlobeNewswire)
Mar-30-26 07:00AM	Patent Board Upholds Seer's Nano and Micro Particle Protein Enrichment Patent in a Challenge by Bruker Subsidiaries (GlobeNewswire)
Mar-04-26 08:00AM	The Radoff-JEC Group Sends Open Letter to Seer, Inc. Unconflicted Independent Directors Meeta Gulyani and Nicolas Roelofs (Business Wire)
Feb-27-26 08:30AM	Seer, Inc. Q4 2025 Earnings Call Summary (Moby) -17.31%
05:45AM	Seer Q4 Earnings Call Highlights (MarketBeat)
12:05AM	Seer Inc (SEER) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Funding Challenges (GuruFocus.com)
Feb-26-26 04:06PM	Seer Adopts Limited Duration Tax Benefit Preservation Plan to Protect its Valuable Tax Assets (GlobeNewswire)
04:05PM	Loading…
04:05PM	Seer Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Outlook (GlobeNewswire)
Feb-25-26 07:41AM	What To Expect From Seer Inc (SEER) Q4 2025 Earnings (GuruFocus.com)
Feb-23-26 08:30AM	The Radoff-JEC Group Issues Open Letter to Seer Inc.'s Board of Directors Regarding the Immediate Need for Significant Change (Business Wire)
Feb-19-26 07:00AM	Leading Scientists Demonstrate How Seer's Proteograph Product Suite Advances Cardiovascular and Neurodegenerative Research at US HUPO 2026 (GlobeNewswire)
Feb-18-26 04:05PM	Seer to Participate in the TD Cowen 46th Annual Health Care Conference (GlobeNewswire)
Feb-05-26 04:05PM	Seer to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 (GlobeNewswire)
Dec-01-25 07:00AM	Nature Genetics Study Validates Seer's Proteograph Platform as Essential for Turning Genetic Signals Into Reliable Drug Targets and Biomarkers (GlobeNewswire)
Nov-07-25 07:00AM	Seer and Collaborators Unveil Broad New Data Demonstrating the Translational Power of Deep Proteomics at HUPO 2025 (GlobeNewswire)
Nov-06-25 04:05PM	Seer Reports Third Quarter 2025 Financial Results (GlobeNewswire)
Nov-05-25 07:59AM	Seer Inc (SEER) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-29-25 04:05PM	Seer to Participate in Upcoming November Investor Conferences (GlobeNewswire)
Oct-16-25 04:05PM	Seer to Report Third Quarter 2025 Financial Results on November 6, 2025 (GlobeNewswire)
Oct-10-25 07:00AM	Seer Highlights How Proteomics Complements Genomics to Advance Precision Medicine at American Society of Human Genetics (ASHG) 2025 (GlobeNewswire)
Sep-02-25 07:00AM	Seer Appoints Isaac Ro to its Board of Directors (GlobeNewswire)
Aug-26-25 04:05PM	Seer to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference (GlobeNewswire)
Aug-06-25 06:45PM	Seer, Inc. (SEER) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
04:05PM	Seer Reports Second Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook (GlobeNewswire)
Aug-05-25 10:31AM	Seer Inc (SEER) Q2 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Jul-31-25 04:05PM	Seer to Participate in the Canaccord Genuity 45th Annual Growth Conference (GlobeNewswire)
Jul-22-25 04:05PM	Seer to Report Second Quarter 2025 Financial Results on August 6, 2025 (GlobeNewswire)
Jun-10-25 12:00PM	What Makes Seer, Inc. (SEER) a Strong Momentum Stock: Buy Now? (Zacks)
Jun-01-25 07:00AM	Seer's Proteograph Platform Enables Unprecedented 20,000-Sample Proteomics Study with Korea University to Develop AI-Driven Diagnostics for Cancers in Young Adults (GlobeNewswire)
May-29-25 07:00AM	Seer Redefining Deep Unbiased Proteomics with Launch of New Proteograph Workflow at ASMS 2025, Enabling Previously Unattainable Scale and Efficiency (GlobeNewswire)
May-14-25 08:10AM	Q1 2025 Seer Inc Earnings Call (Thomson Reuters StreetEvents) +9.90%
03:15AM	Seer Inc (SEER) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges (GuruFocus.com)
May-13-25 05:15PM	Seer, Inc. (SEER) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Seer Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook (GlobeNewswire)
May-12-25 09:44AM	What To Expect From Seer Inc (SEER) Q1 2025 Earnings (GuruFocus.com)
07:25AM	CytomX Therapeutics (CTMX) Beats Q1 Earnings and Revenue Estimates (Zacks)
May-08-25 08:25AM	Royalty Pharma (RPRX) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
May-05-25 05:45PM	AnaptysBio, Inc. (ANAB) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
Apr-24-25 04:05PM	Seer to Report First Quarter 2025 Financial Results on May 13, 2025 (GlobeNewswire)
Mar-25-25 09:35AM	After Plunging -16.59% in 4 Weeks, Here's Why the Trend Might Reverse for Seer (SEER) (Zacks)
Mar-24-25 09:35AM	After Plunging -16.81% in 4 Weeks, Here's Why the Trend Might Reverse for Seer (SEER) (Zacks)
Mar-06-25 09:35AM	Down -10.53% in 4 Weeks, Here's Why Seer (SEER) Looks Ripe for a Turnaround (Zacks)
Feb-28-25 11:38AM	Q4 2024 Seer Inc Earnings Call (Thomson Reuters StreetEvents)
02:39AM	Seer Inc (SEER) Q4 2024 Earnings Call Highlights: Navigating Revenue Decline with Strategic ... (GuruFocus.com)
Feb-27-25 06:40PM	Seer, Inc. (SEER) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Seer Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Outlook (GlobeNewswire)
Feb-26-25 08:16AM	Seer Inc (SEER) Q4 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
Feb-21-25 07:00AM	Seer to Participate in the TD Cowen 45th Annual Health Care Conference (GlobeNewswire)
Feb-20-25 07:00AM	Seer to Feature Proteomic Advancements in Cancer and RNA Therapy Research among other Findings at US HUPO 2025 (GlobeNewswire)
Feb-13-25 04:15PM	Seer to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 (GlobeNewswire)
Jan-02-25 04:05PM	Seer to Present at the J.P. Morgan 43rd Annual Healthcare Conference (GlobeNewswire) +6.01%
Nov-21-24 04:05PM	Seer Ranked Number 57 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500 (GlobeNewswire)
Nov-08-24 07:00AM	Seer to Participate in Upcoming November Investor Conferences (GlobeNewswire) +7.21%
Nov-07-24 02:23AM	Seer Inc (SEER) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com) +7.25%
Nov-06-24 06:00PM	Seer, Inc. (SEER) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Seer Reports Third Quarter 2024 Financial Results (GlobeNewswire)
04:03PM	Seer Enters into a Co-Marketing and Sales Agreement with Thermo Fisher Scientific (GlobeNewswire)
Nov-05-24 08:07AM	Earnings To Watch: Seer Inc (SEER) Reports Q3 2024 Result (GuruFocus.com)
Oct-31-24 07:00AM	Seer Highlights Capability of Deep Proteomics to Enhance Genomic Insights Into Alzheimer's, Lung Cancer, and More at ASHG 2024 (GlobeNewswire)
Oct-21-24 07:00AM	Seer Showcases Scalable Proteomic Advancements Impacting Alzheimer's, Population Health, and Xenotransplantation at HUPO 2024 (GlobeNewswire)
Oct-17-24 04:05PM	Seer to Report Third Quarter 2024 Financial Results on November 6, 2024 (GlobeNewswire)
Oct-09-24 05:59PM	Seer Inc (SEER) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges Amid Strategic ... (GuruFocus.com)
Aug-22-24 04:05PM	Seer to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference (GlobeNewswire)
Aug-14-24 04:05PM	Seer Appoints Nicolas Roelofs to its Board of Directors (GlobeNewswire)
Aug-09-24 07:00AM	Seer to Participate in the Canaccord Genuity 44th Annual Growth Conference (GlobeNewswire)
Aug-08-24 09:56PM	SEER Stock Earnings: Seer Beats EPS, Misses Revenue for Q2 2024 (InvestorPlace)
06:20PM	Seer, Inc. (SEER) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Seer Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Jul-18-24 04:03PM	Seer to Report Second Quarter 2024 Financial Results on August 8, 2024 (GlobeNewswire)
Jun-11-24 11:11AM	Seer Proteograph Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker Discovery (GlobeNewswire)
Jun-02-24 10:55AM	Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ's Early Cancer Detection Study (GlobeNewswire)
May-10-24 03:51PM	Seer Inc (SEER) Q1 2024 Earnings: Revenue Declines but Losses Narrow, Meeting Some Analyst ... (GuruFocus.com)
May-09-24 02:38PM	Seer, Inc. (NASDAQ:SEER) Q1 2024 Earnings Call Transcript (Insider Monkey) -7.62%
07:11AM	Q1 2024 Seer Inc Earnings Call (Thomson Reuters StreetEvents)
03:49AM	Seer Inc (SEER) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges with ... (GuruFocus.com)
May-08-24 09:57PM	SEER Stock Earnings: Seer Meets EPS, Misses Revenue for Q1 2024 (InvestorPlace)
06:45PM	Seer, Inc. (SEER) Reports Q1 Loss, Misses Revenue Estimates (Zacks)

Seer, Inc. (California) engages in the development of proprietary engineered nanoparticles to provide access across the proteome. Its Proteograph product suite comprises automation instrument and software, which provides workflow to make proteomic profiling. The company was founded by Philip Ma, Robert S. Langer Jr. and Omid C. Farokhzad on March 16, 2017 and is headquartered in Redwood City, CA.

Ph.D.Dr. Omid C. Farokhzad M.D.

PresidentMr. David R. Horn

Chief Operations & Product OfficerKenny Ross

Chief People OfficerMs. Marissa Dixon

Chief Data OfficerDr. Serafim Batzoglou Ph.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Horn David R.	PRESIDENT & CFO	May 20 '26	Sale	1.69	7,303	12,352	493,959	May 21 05:12 PM
Horn David R.	PRESIDENT & CFO	Feb 18 '26	Sale	1.99	7,743	15,447	501,262	Feb 19 04:11 PM
Farokhzad Omid	CEO AND CHAIR	Feb 18 '26	Sale	1.99	24,385	48,646	3,349,064	Feb 19 04:06 PM
Horn David R.	PRESIDENT & CFO	Nov 19 '25	Sale	1.97	6,797	13,400	436,802	Nov 21 05:31 PM
Farokhzad Omid	CEO AND CHAIR	Nov 19 '25	Sale	1.97	33,838	66,708	1,238,230	Nov 21 05:29 PM
Horn David R.	PRESIDENT & CFO	Aug 20 '25	Sale	2.04	6,827	13,955	436,802	Aug 21 04:19 PM
Farokhzad Omid	CEO AND CHAIR	Aug 20 '25	Sale	2.04	33,992	69,483	1,272,068	Aug 21 04:18 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

$100 Off Your First Year Get Elite For Just $199.50

SEER

Seer Inc

Upgrade your Finviz experience